Published 2021 | Version v1
Publication

Effects of the GPR17 antagonist montelukast on oligodendrocyte dysfunction and disease outcome in the SOD1G93A mouse model of ALS

Additional details

Created:
April 14, 2023
Modified:
November 28, 2023